Use of non-anthracycline regimens in early stage breast cancer in Australia
Author:
Publisher
Wiley
Subject
Oncology,General Medicine
Reference35 articles.
1. “Daunomycin”, a new antibiotic of the rhodomycin group;Di Marco;Nature,1964
2. Adjuvant chemotherapy in postmenopausal women: results of sequential noncross-resistant regimens;Brambilla;World J Surg,1985
3. Two months of doxorubicin-cyclophosphamide with and without interval reinduction therapy compared with 6 months of cyclophosphamide, methotrexate, and fluorouracil in positive-node breast cancer patients with tamoxifen-nonresponsive tumors: results from the National Surgical Adjuvant Breast and Bowel Project B-15;Fisher;J Clin Oncol,1990
4. Randomized trial comparing cyclophosphamide, epirubicin, and fluorouracil with cyclophosphamide, methotrexate, and fluorouracil in premenopausal women with node-positive breast cancer: update of National Cancer Institute of Canada clinical trials group trial MA5;Levine;J Clin Oncol,2005
5. Benefit of a high-dose epirubicin regimen in adjuvant chemotherapy for node-positive breast cancer patients with poor prognostic factors: 5-year follow-up results of french adjuvant study group 05 randomized trial;French Adjuvant Study Group.;J Clin Oncol,2001
Cited by 7 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Natural products derived from medicinal plants and microbes might act as a game-changer in breast cancer: a comprehensive review of preclinical and clinical studies;Critical Reviews in Food Science and Nutrition;2022-07-15
2. Anthracyclines in the treatment of patients with early breast cancer;ESMO Open;2022-06
3. Chemotherapy regimen choice and patient outcomes in early-stage triple-negative breast cancer: a retrospective analysis;Therapeutic Advances in Medical Oncology;2022-01
4. Treatment patterns for adjuvant docetaxel-based chemotherapy in early-stage breast cancer in China: A pooled retrospective analysis of four observational studies;Chinese Journal of Cancer Research;2018
5. Safety Results of Docetaxel-(Taxotere®)-Based Chemotherapy in Early Breast Cancer Patients of Asia-Pacific Region: Asia-Pacific Breast Initiative II;Journal of Breast Cancer;2015
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3